Your browser doesn't support javascript.
loading
Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer / 国际肿瘤学杂志
Article de Zh | WPRIM | ID: wpr-1018193
Bibliothèque responsable: WPRO
ABSTRACT
The high intra- and inter-tumor heterogeneity of gastric cancer leads to a great difference in the immunotherapy efficacy and the prognosis among patients. Several biomarkers, including programmed death-ligand 1, human epidermal growth factor receptor 2, the features of tumor microenvironment, the peripheral blood inflammatory markers and Claudin18.2 have predictive value in the immunotherapy efficacy and the prognosis of gastric cancer patients, which might help the clinicians find the potential patients who will benefit from immunotherapy, and achieve the goal of precision medicine.
Mots clés
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Journal of International Oncology Année: 2024 Type: Article
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Journal of International Oncology Année: 2024 Type: Article